Medical Technology Development Program News Today

<p>From lab-grown chicken to cricket-derived protein, these innovative alternatives offer hope for a planet struggling with the environmental and ethical impacts of industrial agriculture. Now, Korean scientists add a new recipe to the list—cultured beef rice—by growing animal muscle and fat cells inside rice grains. The method, presented February 14 in the journal <em>Matter</em>, results in a nutritious and flavorful hybrid food that, once commerc...

<p><strong>POSTECH and Yonsei University Research Team Develops High-Efficiency Biomedical Implants Ensuring Safety and Longevity. </strong></p>

A groundbreaking anticancer treatment technology that selectively targets cancer cell lysosomes and overcomes drug resistance has been developed by Professor Ja-Hyoung Ryu and his research team in the Department of Chemistry at UNIST.

A research team, affiliated with South Korea's Ulsan National Institute of Science and Technology (UNIST) has developed a groundbreaking anticancer treatment technology that selectively targets cancer cell lysosomes and overcomes drug resistance.

Glaucoma is a common ocular disease in which the optic nerve malfunctions due to the increased intraocular pressure (IOP) caused by drainage canal blocking in the eye.

Allergies are one of the most common health conditions in the world that affect 10 to 20% of Koreans. Although the disorder is accompanied by mild symptoms, it can lead to anaphylaxis, which is a severe and potentially life-threatening hypersensitivi

tmrFebruary 15, 2021 Antibody Isotyping Kit: Introduction Antibody is a blood protein produced in response to a specific antigen. An antibody is also known as immunoglobulin and is generally Y-shaped in structure. Advances in genetic engineering make antibodies, especially monoclonal antibodies, more robust and efficacious as these increase the binding capacity to any type of specific antigen and hence these are very effective as a diagnostics tool to evaluate various infectious diseases. Antib...

 E-Mail IMAGE: From left to right, Prof. Sang Woo Seo, Dr. Jina Yang, Mr. Yong Hee Han view more  Credit: Seoul National University On Feb 5th, Seoul National University, College of Engineering (Dean Kookheon Char) announced that Professor Sang Woo Seos research team (Dr. Jina Yang and Mr. Yong Hee Han (graduate student)) at School of Chemical and Biological Engineering has developed a synthetic protein quality control system to enhance full-length translation in bacteria. This techno...

Abstract Cancer immunotherapy with 4-1BB agonists has limited further clinical development because of dose-limiting toxicity. Here, we developed a bispecific antibody (bsAb; B7-H3×4-1BB), targeting human B7-H3 (hB7-H3) and mouse or human 4-1BB, to restrict the 4-1BB stimulation in tumors. B7-H3×m4-1BB elicited a 4-1BB–dependent antitumor response in hB7-H3–overexpressing tumor models without systemic toxicity. BsAb primarily targets CD8 T cells in the tumor and increases their proliferati...